by Eclosion Team | Nov 3, 2020 | Uncategorized
Genkyotex (Euronext Paris & Brussels: FR0013399474 –GKTX), a biopharmaceutical company and the leader in NOX therapies, announced the closing of the acquisition by Calliditas Therapeutics AB (“Calliditas”; Nasdaq OMX –CALTX; NASDAQ -CALT) of 62.7% of Genkyotex in...